Medifast Inc
MED13.670USD
-0.080-0.58%
交易中 （美东）报价延迟15分钟
150.25M总市值
亏损市盈率 TTM
关于 Medifast Inc 公司
Medifast, Inc. 是一家健康与保健公司。该公司提供基于习惯和教练指导的生活方式解决方案 OPTAVIA，为人们提供全面的方法，帮助他们实现持久的最佳健康和保健。OPTAVIA 的生活方式计划提供经临床验证的健康益处以及基于证据的工具，包括科学开发的产品和由独立教练和社区支持强化的习惯养成框架。通过与虚拟初级保健提供商 LifeMD, Inc (LifeMD) 的合作，OPTAVIA 客户可以获得委员会认证的附属临床医生和药物，例如 GLP-1，以支持肥胖和其他健康状况的治疗计划。OPTAVIA 教练向客户介绍一系列健康习惯，并提供 OPTAVIA 品牌产品，包括 Fuelings 以及 OPTAVIA ACTIVE，这是一系列必需氨基酸补充剂和蛋白粉。其业务通过其子公司开展。
公司简介
公司代码MED
公司名称Medifast Inc
上市日期Dec 30, 1993
CEOMr. Daniel R. (Dan) Chard
员工数量504
证券类型Ordinary Share
年结日Dec 30
公司地址100 International Drive, 18th Floor
城市BALTIMORE
上市交易所NYSE Consolidated
国家United States of America
邮编21202
电话14105818042
网址https://medifastinc.com/
公司代码MED
上市日期Dec 30, 1993
CEOMr. Daniel R. (Dan) Chard
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Elizabeth A. Geary
Ms. Elizabeth A. Geary
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
收入明细
FY2025Q1
FY2024
暂无数据
地区USD
名称
营收
占比
United States
115.73M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 5月29日 周四
更新时间: 5月29日 周四
持股股东
股东类型
持股股东
持股股东
占比
Renaissance Technologies LLC
8.09%
BlackRock Institutional Trust Company, N.A.
7.78%
The Vanguard Group, Inc.
6.95%
Two Sigma Investments, LP
3.96%
Acadian Asset Management LLC
3.51%
Other
69.71%
持股股东
持股股东
占比
Renaissance Technologies LLC
8.09%
BlackRock Institutional Trust Company, N.A.
7.78%
The Vanguard Group, Inc.
6.95%
Two Sigma Investments, LP
3.96%
Acadian Asset Management LLC
3.51%
Other
69.71%
股东类型
持股股东
占比
Investment Advisor
29.85%
Investment Advisor/Hedge Fund
22.33%
Hedge Fund
18.63%
Research Firm
3.60%
Individual Investor
3.30%
Family Office
0.70%
Sovereign Wealth Fund
0.65%
Pension Fund
0.19%
Bank and Trust
0.12%
Other
20.62%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
501
8.67M
78.89%
-4.42M
2025Q1
543
8.84M
80.44%
-4.55M
2024Q4
558
9.50M
86.82%
-4.11M
2024Q3
566
9.73M
88.98%
-4.84M
2024Q2
601
11.02M
100.79%
-3.10M
2024Q1
608
12.20M
111.59%
-579.67K
2023Q4
629
10.91M
100.15%
-1.24M
2023Q3
641
10.20M
93.63%
-1.89M
2023Q2
664
10.18M
93.46%
-1.94M
2023Q1
682
10.76M
99.19%
-441.80K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Renaissance Technologies LLC
888.93K
8.09%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
855.39K
7.78%
+13.69K
+1.63%
Mar 31, 2025
The Vanguard Group, Inc.
763.56K
6.95%
+15.94K
+2.13%
Mar 31, 2025
Two Sigma Investments, LP
435.72K
3.96%
-12.35K
-2.76%
Mar 31, 2025
Acadian Asset Management LLC
385.72K
3.51%
+113.11K
+41.49%
Mar 31, 2025
D. E. Shaw & Co., L.P.
333.45K
3.03%
+44.66K
+15.47%
Mar 31, 2025
BofA Global Research (US)
288.51K
2.63%
+12.44K
+4.51%
Mar 31, 2025
Charles Schwab Investment Management, Inc.
265.57K
2.42%
+151.43K
+132.68%
Mar 31, 2025
Geode Capital Management, L.L.C.
256.48K
2.33%
+10.55K
+4.29%
Mar 31, 2025
American Century Investment Management, Inc.
224.94K
2.05%
-19.24K
-7.88%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Federated Hermes MDT Small Cap Core ETF
0.27%
First Trust Active Factor Small Cap ETF
0.19%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.14%
Vanguard US Value Factor ETF
0.09%
iShares US Small Cap Value Factor ETF
0.07%
iShares US Small-Cap Equity Factor ETF
0.05%
Schwab Fundamental U.S. Small Company ETF
0.05%
Vanguard US Quality Factor ETF
0.04%
Vanguard US Multifactor ETF
0.03%
iShares Micro-Cap ETF
0.03%
查看更多
Federated Hermes MDT Small Cap Core ETF
占比0.27%
First Trust Active Factor Small Cap ETF
占比0.19%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
占比0.14%
Vanguard US Value Factor ETF
占比0.09%
iShares US Small Cap Value Factor ETF
占比0.07%
iShares US Small-Cap Equity Factor ETF
占比0.05%
Schwab Fundamental U.S. Small Company ETF
占比0.05%
Vanguard US Quality Factor ETF
占比0.04%
Vanguard US Multifactor ETF
占比0.03%
iShares Micro-Cap ETF
占比0.03%
分红派息
近5年累计派现
262.40M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Sep 07, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Nov 07, 2023 going ex on Sep 18, 2023
Sep 19, 2023
Nov 07, 2023
Sep 18, 2023
Jun 15, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Aug 08, 2023 going ex on Jun 26, 2023
Jun 27, 2023
Aug 08, 2023
Jun 26, 2023
Mar 16, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on May 09, 2023 going ex on Mar 27, 2023
Mar 28, 2023
May 09, 2023
Mar 27, 2023
Dec 08, 2022
MED.NB Final Cash Dividend of gross USD 1.64 paid on Feb 07, 2023 going ex on Dec 19, 2022
Dec 20, 2022
Feb 07, 2023
Dec 19, 2022
Sep 08, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Nov 08, 2022 going ex on Sep 19, 2022
Sep 20, 2022
Nov 08, 2022
Sep 19, 2022
Jun 16, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Aug 08, 2022 going ex on Jun 27, 2022
Jun 28, 2022
Aug 08, 2022
Jun 27, 2022
Mar 17, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on May 09, 2022 going ex on Mar 28, 2022
Mar 29, 2022
May 09, 2022
Mar 28, 2022
Dec 08, 2021
MED.NB Final Cash Dividend of gross USD 1.42 paid on Feb 08, 2022 going ex on Dec 20, 2021
Dec 21, 2021
Feb 08, 2022
Dec 20, 2021
Sep 09, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Nov 08, 2021 going ex on Sep 20, 2021
Sep 21, 2021
Nov 08, 2021
Sep 20, 2021
Jun 03, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Aug 06, 2021 going ex on Jun 21, 2021
Jun 22, 2021
Aug 06, 2021
Jun 21, 2021
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
